The dynamic and changing epidemiology of meningococcal disease at the country-based level: The experience in Turkey

Expert Review of Vaccines

Volumn 11, Issue 5, 2012, Pages 515-518

  Dinleyici, Ener Cagri ^a   Ceyhan, Mehmet ^b  

^a Eskisehir Osmangazi Medical Faculty   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

epidemiology; invasive meningococcal disease; Neisseria meningitidis; Turkey

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN G; MENINGOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

BACTERIAL STRAIN; DISEASE TRANSMISSION; EPIDEMIC; HAEMOPHILUS INFLUENZAE TYPE B; HEALTH CARE POLICY; HERD IMMUNITY; HIGH RISK POPULATION; HUMAN; IMMUNIZATION; INCIDENCE; INFECTION SENSITIVITY; MALAYSIA; MENINGOCOCCOSIS; MORTALITY; NEISSERIA MENINGITIDIS; NIGER; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REVIEW; SAUDI ARABIA; SEROEPIDEMIOLOGY; SINGAPORE; STREPTOCOCCUS PNEUMONIAE; TRAVEL; TURKEY (REPUBLIC); VACCINATION;

EID: 84862535312     PISSN: 14760584     EISSN: 17448395     Source Type: Journal    
DOI: 10.1586/erv.12.29     Document Type: Review

References (20)

1. Khatami A, Pollard AJ. The epidemiology of meningococcal disease and the impact of vaccines. Expert Rev. Vaccines 9(3), 285-298 (2010
2. Halperin SA, Bettinger JA, Greenwood B et al. The changing and dynamic epidemiology of meningococcal disease. Vaccine doi:10.1016/j.vaccine.2011.12.032 (2011) (Epub ahead of print
3. Bakir M, Yagci A, Ulger N, Akbenlioglu C, Ilki A, Soyletir G. Asymtomatic carriage of Neisseria meningitidis and Neisseria lactamica in relation to Streptococcus pneumoniae and Haemophilus influenzae colonization in healthy children: apropos of 1400 children sampled. Eur. J. Epidemiol. 17(11), 1015-1018 (2001
4. Ercis S, Köseoglu O, Salmanzadeh-Ahrabi S, Ercis M, Akin L, Hasçelik C. The prevalence of nasopharyngeal Neisseria meningitidis carriage, serogroup distribution, and antibiotic resistance among healthy children in Cankaya municipality schools of Ankara province. Mikrobiyol. Bul. 39(4), 411-420 (2005
5. Akyildiz B, Uzel N, Citak A, Soysal D, Karabocuoglu M, Ucsel R. The factors affecting mortality in meningococcal disease. Çocuk Sagligi ve Hastaliklari Dergisi 51, 26-30 (2008
6. Berkman E, Ozben G. Meningococcic meningitis epidemic in Ankara. Mikrobiyol. Bul. 16(2), 101-106 (1982
7. Ceyhan M, Yildirim I, Balmer P et al. A prospective study of etiology of childhood acute bacterial meningitis, Turkey. Emerging Infect. Dis. 14(7), 1089-1096 (2008
8. Ceyhan M, Yildirim I, Gunes A et al. Serotype shift of Neisseria meningitidis from W135 to B in Turkish children with meningitis. Presented at: 6th World Congress of the World Society for Pediatric Infectious Diseases (WSPID 2011). Buenos Aires, Argentina, 18-22 November 2009.
9. Collard JM, Maman Z, Yacouba H et al. Increase in Neisseria meningitidis serogroup W135, Niger, 2010. Emerging Infect. Dis. 16(9), 1496-1498 (2010
10. Sáfadi MA, Cintra OA. Epidemiology of meningococcal disease in Latin America: current situation and opportunities for prevention. Neurol. Res. 32(3), 263-271 (2010
11. Ceyhan M, Yildirim I, Balmer P et al. Age-specific seroprevalence of serogroup C meningococcal serum bactericidal antibody activity and serogroup A, C, W135 and Y-specific IgG concentrations in the Turkish population during 2005. Vaccine 25(41), 7233-7237 (2007
12. Harrison LH, Shutt KA, Schmink SE et al. Population structure and capsular switching of invasive Neisseria meningitidis isolates in the pre-meningococcal conjugate vaccine era - United States, 2000-2005. J. Infect. Dis. 201(8), 1208-1224 (2010
13. CDC. Updated recommendations for use of meningococcal conjugate vaccines - Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb. Mortal. Wkly Rep. 60(3), 72-76 (2011
14. Turhan V, Acar A, Kiliç A et al. Meningococcemia and meningitis due to Neisseria meningitidis W135 developed in two cases vaccinated with bivalent (A/C) meningococcal vaccine. Mikrobiyol. Bul. 44(3), 473-478 (2010
15. Kiliç A, Bedir O, Basustaoglu AC, Bratcher HB, Jolley KA, Mert G. Neisseria meningitidis serogroup X sequence type 767 in Turkey. J. Clin. Microbiol. 48(11), 4340-4341 (2010
16. Health conditions for travellers to Saudi Arabia for the pilgrimage to Mecca(Hajj). Wkly Epidemiol. Rec. 86(39), 425-428 (2011
17. Wilder-Smith A, Chow A, Goh KT. Emergence and disappearance of W135 meningococcal disease. Epidemiol. Infect. 138(7), 976-978 (2010
18. Wilder-Smith A, Barkham TM, Earnest A, Paton NI. Acquisition of W135 meningococcal carriage in Hajj pilgrims and transmission to household contacts: prospective study. BMJ 325(7360), 365-366 (2002
19. Ceyhan M, Celik M, Demir ET et al. A prospective study of meningococcal carriage among Hajj pilgrims and their household contacts in Turkey 2010. Presented at: 7th World Congress of the World Society for Pediatric Infectious Diseases (WSPID 2011). Melbourne, Australia, 16-19 November 2011.
20. Gossger N, Snape MD, Yu LM et al.; European MenB Vaccine Study Group. Immunogenicity and tolerability of recombinant serogroup B meningococcal vaccine administered with or without routine infant vaccinations according to different immunization schedules: a randomized controlled trial. JAMA 307(6), 573-582 (2012)